Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario De Alcubierre

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Clinical Endocrinology|December 24, 2024
Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical ManagementEsmeralda Cela, Dario De Alcubierre, Emilia Sbardella
Annual Review of Medicine|November 1, 2024
New Approaches to the Treatment of HypercortisolismRiccardo Pofi, Dario De Alcubierre, Jiawen Dong, et al.
Expert Review of Endocrinology & Metabolism|July 31, 2018
The effects of hyperprolactinemia and its control on metabolic diseasesRenata S Auriemma, Dario De Alcubierre, Rosa Pirchio, et al.
Neuroendocrinology|March 11, 2019
Dopamine Agonists: From the 1970s to TodayRenata S Auriemma, Rosa Pirchio, Dario De Alcubierre, et al.
Frontiers in Endocrinology|June 14, 2019
Glucose Abnormalities Associated to Prolactin Secreting Pituitary AdenomasRenata S Auriemma, Dario De Alcubierre, Rosa Pirchio, et al.
Pharmacology & Therapeutics|August 10, 2023
Therapeutic targeting of the pituitary tumor microenvironmentMirela-Diana Ilie, Dario De Alcubierre, Anna Lucia Carretti, et al.
Minerva Endocrinology|January 19, 2024
Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomideDario DE Alcubierre, Anna L Carretti, François Ducray, et al.
Endocrine-Related Cancer|March 18, 2026
Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedsideDario De Alcubierre, Francesca Carbonara, Tiziana Feola, et al.
Journal of the Endocrine Society|December 13, 2024
Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal IncidentalomasIlaria Bonaventura, Marianna Minnetti, Davide Ferrari, et al.
Endocrine-Related Cancer|January 12, 2023
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouseAudrey Ziverec, Marie Chanal, Perrine Raymond, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Clinical Endocrinology|December 24, 2024
Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical ManagementEsmeralda Cela, Dario De Alcubierre, Emilia Sbardella
Annual Review of Medicine|November 1, 2024
New Approaches to the Treatment of HypercortisolismRiccardo Pofi, Dario De Alcubierre, Jiawen Dong, et al.
Expert Review of Endocrinology & Metabolism|July 31, 2018
The effects of hyperprolactinemia and its control on metabolic diseasesRenata S Auriemma, Dario De Alcubierre, Rosa Pirchio, et al.
Neuroendocrinology|March 11, 2019
Dopamine Agonists: From the 1970s to TodayRenata S Auriemma, Rosa Pirchio, Dario De Alcubierre, et al.
Frontiers in Endocrinology|June 14, 2019
Glucose Abnormalities Associated to Prolactin Secreting Pituitary AdenomasRenata S Auriemma, Dario De Alcubierre, Rosa Pirchio, et al.
Pharmacology & Therapeutics|August 10, 2023
Therapeutic targeting of the pituitary tumor microenvironmentMirela-Diana Ilie, Dario De Alcubierre, Anna Lucia Carretti, et al.
Minerva Endocrinology|January 19, 2024
Aggressive pituitary tumors and carcinomas: medical treatment beyond temozolomideDario DE Alcubierre, Anna L Carretti, François Ducray, et al.
Endocrine-Related Cancer|March 18, 2026
Ageing and pituitary neuroendocrine tumours (PitNETs): from bench to bedsideDario De Alcubierre, Francesca Carbonara, Tiziana Feola, et al.
Journal of the Endocrine Society|December 13, 2024
Impact of Female Sex and Mild Cortisol Secretion on Coagulation Profile in Adrenal IncidentalomasIlaria Bonaventura, Marianna Minnetti, Davide Ferrari, et al.
Endocrine-Related Cancer|January 12, 2023
Inhibition of activin signalling reduces the growth of LβT2 gonadotroph pituitary tumours in mouseAudrey Ziverec, Marie Chanal, Perrine Raymond, et al.
Pageof 3